Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease
Sep. 13, 14 & 15, 2023
at Mass General Brigham, Assembly Row
399 Revolution Drive, Somerville, MA 02145
Hybrid Course (Offered On-line or In-person) &
optional hands on sessions
Charudutt Paranjape, MD, MBBS, FACS
Kumar Krishnan, MD
The annual hybrid Minimally Invasive and Novel Therapeutics (MINT) continuing medical education (CME) course, seeks to equip clinicians with advanced technical knowledge of the latest surgical and endoscopic procedures needed to diagnose and treat foregut disease utilizing novel educational formats such as video-based learning to encourage “technique transfer”.
We further hope to foster ongoing collaboration between gastroenterologists, surgeons, advanced practice providers, nurses, and dietitians to optimize the multidisciplinary care of patients with foregut digestive disease.
The annual conference is both in-person, with an optional hands-on component, and virtual live-streamed (and recorded).
Highlights for MINT 2023 include:
- Pancreas track
- Hernia track
- Optional hands-on sessions in robotic surgery, endoluminal therapies, pancreatitis
- Nursing and APP breakout session
- Now offering Nursing CEUs!
Upon completion of this activity, participants will be able to:
- Apply new knowledge in the management of patients with reflux and swallowing disorders
- Develop treatment strategies based on current evidence and expert opinion
- Compare and contrast standard-of-care management with cutting-edge treatments
Who should attend:
Provider type: Specialty physicians, nurse practitioners, physician assistants, nurses
Specialty: Gastroenterology, Surgery, thoracic surgery, otolaryngology, internal medicine
In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Harvard Medical School designates this hybrid course for a maximum of 22.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Harvard Medical School designates this live activity for a maximum of 22.25 ANCC contact hours.